Skip to content

Evaluation of ApneaLink Plus Scoring Capabilities

Evaluation of ApneaLink Plus Scoring Capabilities

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00823134
Enrollment
23
Registered
2009-01-15
Start date
2008-12-31
Completion date
2009-03-31
Last updated
2020-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Apnea, Central, Sleep Apnea, Obstructive

Brief summary

The purpose of this study is to investigate the following topics: * Determine the accuracy of ApneaLink Plus in separating Apneas into Obstructive Apneas, Mixed Apneas and Central Apneas. * Determine the accuracy of ApneaLink Plus in scoring Hypopneas according to the 2008 guidelines of the AASM = American Academy of Sleep Medcine. * Determine whether patients can start and stop the recorder and are able to attach the additional effort sensor by themselves using the patient instruction sheet

Detailed description

* Determine the accuracy of ApneaLink Plus in separating Apneas into Obstructive Apneas, Mixed Apneas and Central Apneas. * Determine the accuracy of ApneaLink Plus in scoring Hypopneas according to the 2008 guidelines of the AASM = American Academy of Sleep Medcine. * Determine whether patients can start and stop the recorder and are able to attach the additional effort sensor by themselves using the patient instruction sheet

Interventions

DEVICEApneaLink Plus

Device used to evaluate for the presence of obstructive, central or mixed apneas

Sponsors

ResMed
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Willing to give written informed consent * Adult patients who are 18 years of age or older * No alcohol consumption 12 hrs before and during the trial period * Normally sleep more than 3 hours per night

Exclusion criteria

* Unable to comprehend written and spoken German. * Pregnant * Patients who use of Bilevel PAP or CPAP therapy during the PSG * Unsuitable for inclusion in the opinion of the investigator

Design outcomes

Primary

MeasureTime frameDescription
Assessment of the Apnoea-Hypopnea-Index (Number of Apneas (All Apneas, Obstructive, Mixed, Central) and Number of Hypopneas) Between ApneaLink Plus and a PSG System Within the Same Evaluation Periodone nightApnoea is defined as a decrease in flow of ≥90% from baseline for at least 10 seconds; hypopnea is a decrease in flow ≥30% from baseline for at least 10 seconds and an oxygen desaturation of ≥4%; obstructive: breathing efforts are ongoing; central: no breathing efforts
Correlation Coefficient of Apnoea-Hypopnea-Index (AHI) (PSG) - AHI (AL)1 nightThe AHI (PSG) values and AHI ApneaLink Plus (AL) value will be collected in one graph (Bland-Altmann Plot) and the correlation coefficient will be calculated. A correlation of \>75% will be seen as threshold for validity.
Correlation Coefficient of Apnoea-Index (AI) (PSG) - AI (AL)1 nightThe AI (PSG) values and AI ApneaLink Plus (AL) value will be collected in one graph (Bland-Altmann Plot) and the correlation coefficient will be calculated. A correlation of \>75% will be seen as threshold for validity.
Correlation Coefficient of Obstructive-Apnoea-Index (OAI) (PSG) - OAI (AL)1 nightThe OAI (PSG) values and OAI ApneaLink Plus (AL) value will be collected in one graph (Bland-Altmann Plot) and the correlation coefficient will be calculated. A correlation of \>75% will be seen as threshold for validity.
Correlation Coefficient of Central-Apnoea-Index (CAI) (PSG) - CAI (AL)1 nightThe CAI (PSG) values and CAI ApneaLink Plus (AL) value will be collected in one graph (Bland-Altmann Plot) and the correlation coefficient will be calculated. A correlation of \>75% will be seen as threshold for validity.
Correlation Coefficient of Apnoea-Index (HI) (PSG) - HI (AL)1 nightThe HI (PSG) values and HI ApneaLink Plus (AL) value will be collected in one graph (Bland-Altmann Plot) and the correlation coefficient will be calculated. A correlation of \>75% will be seen as threshold for validity.
Correlation Coefficient of Obstructive-Apnoea-Index (ODI) (PSG) - ODI (AL)1 nightThe ODI (PSG) values and ODI ApneaLink Plus (AL) value will be collected in one graph (Bland-Altmann Plot) and the correlation coefficient will be calculated. A correlation of \>75% will be seen as threshold for validity.

Countries

Germany

Participant flow

Participants by arm

ArmCount
PSG/ApneaLink
Sleep Evaluation under Polysomnography and with ApneaLink
22
Total22

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyInvalid measurement1

Baseline characteristics

CharacteristicPSG/ApneaLink
Age, Continuous53.73 years
STANDARD_DEVIATION 16.26
Body Mass Index29.77 kg/m2
STANDARD_DEVIATION 4.23
Race and Ethnicity Not Collected— Participants
Region of Enrollment
Germany
22 participants
Sex: Female, Male
Female
3 Participants
Sex: Female, Male
Male
19 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 22
serious
Total, serious adverse events
0 / 22

Outcome results

Primary

Assessment of the Apnoea-Hypopnea-Index (Number of Apneas (All Apneas, Obstructive, Mixed, Central) and Number of Hypopneas) Between ApneaLink Plus and a PSG System Within the Same Evaluation Period

Apnoea is defined as a decrease in flow of ≥90% from baseline for at least 10 seconds; hypopnea is a decrease in flow ≥30% from baseline for at least 10 seconds and an oxygen desaturation of ≥4%; obstructive: breathing efforts are ongoing; central: no breathing efforts

Time frame: one night

ArmMeasureGroupValue (MEAN)Dispersion
PSG/ApneaLinkAssessment of the Apnoea-Hypopnea-Index (Number of Apneas (All Apneas, Obstructive, Mixed, Central) and Number of Hypopneas) Between ApneaLink Plus and a PSG System Within the Same Evaluation PeriodAHI_psg14.77 events/hourStandard Deviation 14.97
PSG/ApneaLinkAssessment of the Apnoea-Hypopnea-Index (Number of Apneas (All Apneas, Obstructive, Mixed, Central) and Number of Hypopneas) Between ApneaLink Plus and a PSG System Within the Same Evaluation PeriodAHI_al12.14 events/hourStandard Deviation 12.04
p-value: 0.021Wilcoxon (Mann-Whitney)
Primary

Correlation Coefficient of Apnoea-Hypopnea-Index (AHI) (PSG) - AHI (AL)

The AHI (PSG) values and AHI ApneaLink Plus (AL) value will be collected in one graph (Bland-Altmann Plot) and the correlation coefficient will be calculated. A correlation of \>75% will be seen as threshold for validity.

Time frame: 1 night

Population: Participant undergoes one night of sleep while wearing an Apnea Link device and polysomnography is being recorded.

ArmMeasureValue (NUMBER)
PSG/ApneaLinkCorrelation Coefficient of Apnoea-Hypopnea-Index (AHI) (PSG) - AHI (AL)0.968 correlation
Comparison: Per recording, the number of events found per category with PSG and ApneaLink Plus will be compared. As a summary, all PSG values and all ApneaLink Plus values per category will be collected in one graph (Bland-Altmann Plot). The correlation coefficient will be calculated per category. A correlation of \>75% will be seen as threshold for validity.
Primary

Correlation Coefficient of Apnoea-Index (AI) (PSG) - AI (AL)

The AI (PSG) values and AI ApneaLink Plus (AL) value will be collected in one graph (Bland-Altmann Plot) and the correlation coefficient will be calculated. A correlation of \>75% will be seen as threshold for validity.

Time frame: 1 night

Population: Participant undergoes one night of sleep while wearing an Apnea Link device and polysomnography is being recorded.

ArmMeasureValue (NUMBER)
PSG/ApneaLinkCorrelation Coefficient of Apnoea-Index (AI) (PSG) - AI (AL)0.935 Correlation
Primary

Correlation Coefficient of Apnoea-Index (HI) (PSG) - HI (AL)

The HI (PSG) values and HI ApneaLink Plus (AL) value will be collected in one graph (Bland-Altmann Plot) and the correlation coefficient will be calculated. A correlation of \>75% will be seen as threshold for validity.

Time frame: 1 night

Population: Participant undergoes one night of sleep while wearing an Apnea Link device and polysomnography is being recorded.

ArmMeasureValue (NUMBER)
PSG/ApneaLinkCorrelation Coefficient of Apnoea-Index (HI) (PSG) - HI (AL)0.754 Correlation
Primary

Correlation Coefficient of Central-Apnoea-Index (CAI) (PSG) - CAI (AL)

The CAI (PSG) values and CAI ApneaLink Plus (AL) value will be collected in one graph (Bland-Altmann Plot) and the correlation coefficient will be calculated. A correlation of \>75% will be seen as threshold for validity.

Time frame: 1 night

Population: Participant undergoes one night of sleep while wearing an Apnea Link device and polysomnography is being recorded.

ArmMeasureValue (NUMBER)
PSG/ApneaLinkCorrelation Coefficient of Central-Apnoea-Index (CAI) (PSG) - CAI (AL)0.939 Correlation
Primary

Correlation Coefficient of Obstructive-Apnoea-Index (OAI) (PSG) - OAI (AL)

The OAI (PSG) values and OAI ApneaLink Plus (AL) value will be collected in one graph (Bland-Altmann Plot) and the correlation coefficient will be calculated. A correlation of \>75% will be seen as threshold for validity.

Time frame: 1 night

Population: Participant undergoes one night of sleep while wearing an Apnea Link device and polysomnography is being recorded.

ArmMeasureValue (NUMBER)
PSG/ApneaLinkCorrelation Coefficient of Obstructive-Apnoea-Index (OAI) (PSG) - OAI (AL)0.852 Correlation
Primary

Correlation Coefficient of Obstructive-Apnoea-Index (ODI) (PSG) - ODI (AL)

The ODI (PSG) values and ODI ApneaLink Plus (AL) value will be collected in one graph (Bland-Altmann Plot) and the correlation coefficient will be calculated. A correlation of \>75% will be seen as threshold for validity.

Time frame: 1 night

Population: Participant undergoes one night of sleep while wearing an Apnea Link device and polysomnography is being recorded.

ArmMeasureValue (NUMBER)
PSG/ApneaLinkCorrelation Coefficient of Obstructive-Apnoea-Index (ODI) (PSG) - ODI (AL)0.905 Correlation

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026